2VEY - JenaLib

Asymmetric/Biological Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain A from PDB  Type:PROTEIN  Length:298
 aligned with PTN1_HUMAN | P18031 from UniProtKB/Swiss-Prot  Length:435

    Alignment length:298
                                    12        22        32        42        52        62        72        82        92       102       112       122       132       142       152       162       172       182       192       202       212       222       232       242       252       262       272       282       292        
           PTN1_HUMAN     3 MEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLE 300
               SCOP domains d2veya_ A: Tyrosine phosphatase                                                                                                                                                                                                                                                                            SCOP domains
               CATH domains 2veyA00 A:3-300 Protein tyrosine phosphatase superfamily                                                                                                                                                                                                                                                   CATH domains
               Pfam domains ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author hhhhhhhhhhhhhhhhhhhhhhhhh.........hhhhhhhh........................eeeeee....eeeeee......hhhhhhhhhhhh...eeee....ee..ee.............ee.hhh.eeeeeeeeee...eeeeeeeeee.....eeeeeeeee..........hhhhhhhhhhhhhhh.........eeee.....hhhhhhhhhhhhhhhhhhh.hhhhhhhhhhhhhhh........hhhhhhhhhhhhhhhhhhhh...hhhhhhhhhhh.... Sec.struct. author
                 SAPs(SNPs) ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                PROSITE (1) TYR_PHOSPHATASE_PTP  PDB: A:3-277 UniProt: 3-277                                                                                                                                                                                                                                   ----------------------- PROSITE (1)
                PROSITE (2) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------TYR_PHOSPHATASE_2  PDB: A:189-268 UniProt: 189-268                              -------------------------------- PROSITE (2)
                PROSITE (3) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------TYR_PHOSPHA----------------------------------------------------------------------------- PROSITE (3)
           Transcript 1 (1) Exon 1.1           Exon 1.2  PDB: A:22-52         ---------------------------------Exon 1.4  PDB: A:86-118          Exon 1.5  PDB: A:119-164 UniProt: 119-164     Exon 1.6  PDB: A:165-234 UniProt: 165-234                             Exon 1.7  PDB: A:235-288 UniProt: 235-288             Exon 1.8     Transcript 1 (1)
           Transcript 1 (2) -------------------------------------------------Exon 1.3  PDB: A:52-85            ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Transcript 1 (2)
                 2vey A   3 MEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLE 300
                                    12        22        32        42        52        62        72        82        92       102       112       122       132       142       152       162       172       182       192       202       212       222       232       242       252       262       272       282       292

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

Classification and Annotation

SCOP Domains (1, 1)

CATH Domains (1, 1)

Pfam Domains (0, 0)

Gene Ontology (51, 51)

Asymmetric/Biological Unit(hide GO term definitions)

Chain A (PTN1_HUMAN | P18031)

molecular function
	GO:0019899	enzyme binding	Interacting selectively and non-covalently with any enzyme.
	GO:0046875	ephrin receptor binding	Interacting selectively and non-covalently with an ephrin receptor.
	GO:0016787	hydrolase activity	Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.
	GO:0005158	insulin receptor binding	Interacting selectively and non-covalently with the insulin receptor.
	GO:0016791	phosphatase activity	Catalysis of the hydrolysis of phosphoric monoesters, releasing inorganic phosphate.
	GO:0004721	phosphoprotein phosphatase activity	Catalysis of the reaction: a phosphoprotein + H2O = a protein + phosphate. Together with protein kinases, these enzymes control the state of phosphorylation of cell proteins and thereby provide an important mechanism for regulating cellular activity.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0019901	protein kinase binding	Interacting selectively and non-covalently with a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.
	GO:0051721	protein phosphatase 2A binding	Interacting selectively and non-covalently with the enzyme protein phosphatase 2A.
	GO:0004725	protein tyrosine phosphatase activity	Catalysis of the reaction: protein tyrosine phosphate + H2O = protein tyrosine + phosphate.
	GO:0030971	receptor tyrosine kinase binding	Interacting selectively and non-covalently with a receptor that possesses protein tyrosine kinase activity.
	GO:0008270	zinc ion binding	Interacting selectively and non-covalently with zinc (Zn) ions.
biological process
	GO:0036498	IRE1-mediated unfolded protein response	A series of molecular signals mediated by the endoplasmic reticulum stress sensor IRE1 (Inositol-requiring transmembrane kinase/endonuclease). Begins with activation of IRE1 in response to endoplasmic reticulum (ER) stress, and ends with regulation of a downstream cellular process, e.g. transcription. One target of activated IRE1 is the transcription factor HAC1 in yeast, or XBP1 in mammals; IRE1 cleaves an intron of a mRNA coding for HAC1/XBP1 to generate an activated HAC1/XBP1 transcription factor, which controls the up regulation of UPR-related genes. At least in mammals, IRE1 can also signal through additional intracellular pathways including JNK and NF-kappaB.
	GO:0060397	JAK-STAT cascade involved in growth hormone signaling pathway	The process in which STAT proteins (Signal Transducers and Activators of Transcription) are activated by members of the JAK (janus activated kinase) family of tyrosine kinases, following the binding of physiological ligands to the growth hormone receptor. Once activated, STATs dimerize and translocate to the nucleus and modulate the expression of target genes.
	GO:0031532	actin cytoskeleton reorganization	A process that is carried out at the cellular level which results in dynamic structural changes to the arrangement of constituent parts of cytoskeletal structures comprising actin filaments and their associated proteins.
	GO:0007257	activation of JUN kinase activity	The initiation of the activity of the inactive enzyme JUN kinase (JNK).
	GO:0006987	activation of signaling protein activity involved in unfolded protein response	The conversion of a specific protein, possessing protein kinase and endoribonuclease activities, to an active form as a result of signaling via the unfolded protein response.
	GO:0016311	dephosphorylation	The process of removing one or more phosphoric (ester or anhydride) residues from a molecule.
	GO:0030968	endoplasmic reticulum unfolded protein response	The series of molecular signals generated as a consequence of the presence of unfolded proteins in the endoplasmic reticulum (ER) or other ER-related stress; results in changes in the regulation of transcription and translation.
	GO:0008286	insulin receptor signaling pathway	The series of molecular signals generated as a consequence of the insulin receptor binding to insulin.
	GO:0070373	negative regulation of ERK1 and ERK2 cascade	Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
	GO:0043407	negative regulation of MAP kinase activity	Any process that stops, prevents, or reduces the frequency, rate or extent of MAP kinase activity.
	GO:1903898	negative regulation of PERK-mediated unfolded protein response	Any process that stops, prevents or reduces the frequency, rate or extent of the PERK-mediated unfolded protein response.
	GO:1902236	negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway	Any process that stops, prevents or reduces the frequency, rate or extent of an endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway.
	GO:0046627	negative regulation of insulin receptor signaling pathway	Any process that stops, prevents, or reduces the frequency, rate or extent of insulin receptor signaling.
	GO:0009968	negative regulation of signal transduction	Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction.
	GO:0030948	negative regulation of vascular endothelial growth factor receptor signaling pathway	Any process that stops, prevents, or reduces the frequency, rate or extent of vascular endothelial growth factor receptor signaling pathway activity.
	GO:0035335	peptidyl-tyrosine dephosphorylation	The removal of phosphoric residues from peptidyl-O-phospho-tyrosine to form peptidyl-tyrosine.
	GO:1990264	peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity	Any peptidyl-tyrosine dephosphorylation that is involved in inactivation of protein kinase activity.
	GO:0035791	platelet-derived growth factor receptor-beta signaling pathway	A series of molecular signals initiated by the binding of a ligand to a beta-type platelet-derived growth factor receptor (PDGFbeta) on the surface of a signal-receiving cell, and ending with regulation of a downstream cellular process, e.g. transcription.
	GO:1903896	positive regulation of IRE1-mediated unfolded protein response	Any process that activates or increases the frequency, rate or extent of the IRE1-mediated unfolded protein response.
	GO:0061098	positive regulation of protein tyrosine kinase activity	Any process that increases the rate, frequency, or extent of protein tyrosine kinase activity.
	GO:2000646	positive regulation of receptor catabolic process	Any process that activates or increases the frequency, rate or extent of receptor catabolic process.
	GO:0006470	protein dephosphorylation	The process of removing one or more phosphoric residues from a protein.
	GO:0030100	regulation of endocytosis	Any process that modulates the frequency, rate or extent of endocytosis.
	GO:1902202	regulation of hepatocyte growth factor receptor signaling pathway	Any process that modulates the frequency, rate or extent of hepatocyte growth factor receptor signaling pathway.
	GO:0046626	regulation of insulin receptor signaling pathway	Any process that modulates the frequency, rate or extent of insulin receptor signaling.
	GO:0033157	regulation of intracellular protein transport	Any process that modulates the frequency, rate or extent of the directed movement of proteins within cells.
	GO:0009966	regulation of signal transduction	Any process that modulates the frequency, rate or extent of signal transduction.
	GO:0060338	regulation of type I interferon-mediated signaling pathway	Any process that modulates the rate, frequency or extent of a type I interferon-mediated signaling pathway. A type I interferon-mediated signaling pathway is the series of molecular events generated as a consequence of a type I interferon binding to a cell surface receptor.
	GO:0034976	response to endoplasmic reticulum stress	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stress acting at the endoplasmic reticulum. ER stress usually results from the accumulation of unfolded or misfolded proteins in the ER lumen.
cellular component
	GO:0005737	cytoplasm	All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
	GO:0098554	cytoplasmic side of endoplasmic reticulum membrane	The side (leaflet) of the plasma membrane that faces the cytoplasm.
	GO:0031410	cytoplasmic vesicle	A vesicle found in the cytoplasm of a cell.
	GO:0005829	cytosol	The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
	GO:0005769	early endosome	A membrane-bounded organelle that receives incoming material from primary endocytic vesicles that have been generated by clathrin-dependent and clathrin-independent endocytosis; vesicles fuse with the early endosome to deliver cargo for sorting into recycling or degradation pathways.
	GO:0005783	endoplasmic reticulum	The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
	GO:0005789	endoplasmic reticulum membrane	The lipid bilayer surrounding the endoplasmic reticulum.
	GO:0016020	membrane	A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
	GO:0005886	plasma membrane	The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
	GO:0097443	sorting endosome	A multivesicular body surrounded by and connected with multiple tubular compartments with associated vesicles.

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File

1a5y	PROTEIN TYROSINE PHOSPHATASE 1B CYSTEINYL- PHOSPHATEINTERMEDIATE
1aax	CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1BCOMPLEXED WITH TWO BIS(PARA- PHOSPHOPHENYL)METHANE (BPPM)MOLECULES
1bzc	HUMAN PTP1B CATALYTIC DOMAIN COMPLEXED WITH TPI
1bzh	CYCLIC PEPTIDE INHIBITOR OF HUMAN PTP1B
1bzj	HUMAN PTP1B COMPLEXED WITH TPICOOH
1c83	CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1BCOMPLEXED WITH 6-(OXALYL-AMINO )-1H-INDOLE-5-CARBOXYLIC ACID
1c84	CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1BCOMPLEXED WITH 3-(OXALYL-AMINO )-NAPHTHALENE-2-CARBOXLIC ACID
1c85	CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1BCOMPLEXED WITH 2-(OXALYL-AMINO )-BENZOIC ACID
1c86	CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B (R47V,D48N) COMPLEXED WITH 2 -(OXALYL-AMINO-4,7-DIHYDRO-5H-THIENO[2, 3-C]PYRAN- 3-CARBOXYLIC ACID
1c87	CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1BCOMPLEXED WITH 2-(OXALYL-AMINO- 4,7-DIHYDRO-5H-THIENO[2,3-C]PYRAN-3- CARBOXYLIC ACID
1c88	CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1BCOMPLEXED WITH 2-(OXALYL-AMINO )-4,5,6,7-TETRAHYDRO-THIENO[2,3-C] PYRIDINE-3- CARBOXYLIC ACID
1ecv	CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1BCOMPLEXED WITH 5-IODO-2-( OXALYL-AMINO)-BENZOIC ACID
1een	CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1BCOMPLEXED WITH ACETYL-D-A-D- BPA-PTYR-L-I-P-Q-Q-G
1eeo	CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1BCOMPLEXED WITH ACETYL-E-L-E- F-PTYR-M-D-Y-E-NH2
1g1f	CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1BCOMPLEXED WITH A TRI- PHOSPHORYLATED PEPTIDE (RDI(PTR)ETD(PTR)(PTR )RK) FROM THE INSULIN RECEPTOR KINASE
1g1g	CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1BCOMPLEXED WITH A MONO- PHOSPHORYLATED PEPTIDE (ETDY(PTR)RKGGKGLL) FROM THE INSULIN RECEPTOR KINASE
1g1h	CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1BCOMPLEXED WITH A BIS- PHOSPHORYLATED PEPTIDE (ETD(PTR)(PTR)RKGGKGLL ) FROM THE INSULIN RECEPTOR KINASE
1g7f	HUMAN PTP1B CATALYTIC DOMAIN COMPLEXED WITH PNU177496
1g7g	HUMAN PTP1B CATALYTIC DOMAIN COMPLEXES WITH PNU179326
1gfy	RESIDUE 259 IS A KEY DETERMINANT OF SUBSTRATE SPECIFICITYOF PROTEIN- TYROSINE PHOSPHATASE 1B AND ALPHA
1i57	CRYSTAL STRUCTURE OF APO HUMAN PTP1B (C215S ) MUTANT
1jf7	HUMAN PTP1B CATALYTIC DOMAIN COMPLEXED WITH PNU177836
1kak	HUMAN TYROSINE PHOSPHATASE 1B COMPLEXED WITH AN INHIBITOR
1kav	HUMAN TYROSINE PHOSPHATASE 1B COMPLEXED WITH AN INHIBITOR
1l8g	CRYSTAL STRUCTURE OF PTP1B COMPLEXED WITH 7 -(1,1-DIOXO-1H-BENZO[D] ISOTHIAZOL-3- YLOXYMETHYL)-2-(OXALYL-AMINO)-4,7-DIHYDRO- 5H- THIENO[2,3-C]PYRAN-3-CARBOXYLIC ACID
1lqf	STRUCTURE OF PTP1B IN COMPLEX WITH A PEPTIDICBISPHOSPHONATE INHIBITOR
1nl9	POTENT, SELECTIVE PROTEIN TYROSINE PHOSPHATASE 1B INHIBITORCOMPOUND 12 USING A LINKED- FRAGMENT STRATEGY
1nny	POTENT, SELECTIVE PROTEIN TYROSINE PHOSPHATASE 1B INHIBITORCOMPOUND 23 USING A LINKED- FRAGMENT STRATEGY
1no6	POTENT, SELECTIVE PROTEIN TYROSINE PHOSPHATASE 1B INHIBITORCOMPOUND 5 USING A LINKED- FRAGMENT STRATEGY
1nwe	PTP1B R47C MODIFIED AT C47 WITH N-[4-(2 -{2-[3-(2-BROMO-ACETYLAMINO) -PROPIONYLAMINO ]-3-HYDROXY-PROPIONYLAMINO}-ETHYL)-PHENYL]- OXALAMIC ACID
1nwl	CRYSTAL STRUCTURE OF THE PTP1B COMPLEXED WITH SP7343-SP7964,A PTYR MIMETIC
1nz7	POTENT, SELECTIVE INHIBITORS OF PROTEIN TYROSINEPHOSPHATASE 1B USING A SECOND PHOSPHOTYROSINE BINDING SITE,COMPLEXED WITH COMPOUND 19.
1oem	PTP1B WITH THE CATALYTIC CYSTEINE OXIDIZED TO A SULFENYL-AMIDE BOND
1oeo	PTP1B WITH THE CATALYTIC CYSTEINE OXIDIZED TO SULFONIC ACID
1oes	OXIDATION STATE OF PROTEIN TYROSINE PHOSPHATASE 1B
1oet	OXIDATION STATE OF PROTEIN TYROSINE PHOSPHATASE 1B
1oeu	OXIDATION STATE OF PROTEIN TYROSINE PHOSPHATASE 1B
1oev	OXIDATION STATE OF PROTEIN TYROSINE PHOSPHATASE 1B
1ony	OXALYL-ARYL-AMINO BENZOIC ACID INHIBITORS OF PTP1B,COMPOUND 17
1onz	OXALYL-ARYL-AMINO BENZOIC ACID INHIBITORS OF PTP1B,COMPOUND 8B
1pa1	CRYSTAL STRUCTURE OF THE C215D MUTANT OF PROTEIN TYROSINEPHOSPHATASE 1B
1ph0	NON-CARBOXYLIC ACID-CONTAINING INHIBITOR OF PTP1B TARGETINGTHE SECOND PHOSPHOTYROSINE SITE
1ptt	CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1BCOMPLEXED WITH PHOSPHOTYROSINE- CONTAINING TETRA-PEPTIDE(AC-DEPYL-NH2)
1ptu	CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1BCOMPLEXED WITH PHOSPHOTYROSINE- CONTAINING HEXA-PEPTIDE(DADEPYL-NH2)
1ptv	CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1BCOMPLEXED WITH PHOSPHOTYROSINE
1pty	CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1BCOMPLEXED WITH TWO PHOSPHOTYROSINE MOLECULES
1pxh	CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B WITHPOTENT AND SELECTIVE BIDENTATE INHIBITOR COMPOUND 2
1pyn	DUAL-SITE POTENT, SELECTIVE PROTEIN TYROSINE PHOSPHATASE 1BINHIBITOR USING A LINKED FRAGMENT STRATEGY AND A MALONATEHEAD ON THE FIRST SITE
1q1m	A HIGHLY EFFICIENT APPROACH TO A SELECTIVE AND CELL ACTIVEPTP1B INHIBITORS
1q6j	THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEXWITH COMPOUND 2
1q6m	THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEXWITH COMPOUND 3
1q6n	THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEXWITH COMPOUND 4
1q6p	THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEXWITH COMPOUND 6
1q6s	THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEXWITH COMPOUND 9
1q6t	THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEXWITH COMPOUND 11
1qxk	MONOACID-BASED, CELL PERMEABLE, SELECTIVE INHIBITORS OFPROTEIN TYROSINE PHOSPHATASE 1B
1sug	1.95 A STRUCTURE OF APO PROTEIN TYROSINE PHOSPHATASE 1B
1t48	ALLOSTERIC INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B
1t49	ALLOSTERIC INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B
1t4j	ALLOSTERIC INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B
1wax	PROTEIN TYROSINE PHOSPHATASE 1B WITH ACTIVE SITE INHIBITOR
1xbo	PTP1B COMPLEXED WITH ISOXAZOLE CARBOXYLIC ACID
2azr	CRYSTAL STRUCTURE OF PTP1B WITH BICYCLIC THIOPHENE INHIBITOR
2b07	CRYSTAL STRUCTURE OF PTP1B WITH TRICYCLIC THIOPHENEINHIBITOR.
2b4s	CRYSTAL STRUCTURE OF A COMPLEX BETWEEN PTP1B AND THEINSULIN RECEPTOR TYROSINE KINASE
2bgd	STRUCTURE-BASED DESIGN OF PROTEIN TYROSINE PHOSPHATASE-1B INHIBITORS
2bge	STRUCTURE-BASED DESIGN OF PROTEIN TYROSINE PHOSPHATASE-1B INHIBITORS
2cm2	STRUCTURAL OF PROTEIN TYROSINE PHOSPHATASE 1B (P212121)
2cm3	STRUCTURAL OF PROTEIN TYROSINE PHOSPHATASE 1B (C2)
2cm7	STRUCTURAL BASIS FOR INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B BY ISOTHIAZOLIDINONE HETEROCYCLIC PHOSPHONATE MIMETICS
2cm8	STRUCTURAL BASIS FOR INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B BY ISOTHIAZOLIDINONE HETEROCYCLIC PHOSPHONATE MIMETICS
2cma	STRUCTURAL BASIS FOR INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B BY ISOTHIAZOLIDINONE HETEROCYCLIC PHOSPHONATE MIMETICS
2cmb	STRUCTURAL BASIS FOR INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B BY ISOTHIAZOLIDINONE HETEROCYCLIC PHOSPHONATE MIMETICS
2cmc	STRUCTURAL BASIS FOR INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B BY ISOTHIAZOLIDINONE HETEROCYCLIC PHOSPHONATE MIMETICS
2cne	STRUCTURAL INSIGHTS INTO THE DESIGN OF NONPEPTIDIC ISOTHIAZOLIDINONE-CONTAINING INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B
2cnf	STRUCTURAL INSIGHTS INTO THE DESIGN OF NONPEPTIDIC ISOTHIAZOLIDINONE-CONTAINING INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B
2cng	STRUCTURAL INSIGHTS INTO THE DESIGN OF NONPEPTIDIC ISOTHIAZOLIDINONE-CONTAINING INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B
2cnh	STRUCTURAL INSIGHTS INTO THE DESIGN OF NONPEPTIDIC ISOTHIAZOLIDINONE-CONTAINING INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B
2cni	STRUCTURAL INSIGHTS INTO THE DESIGN OF NONPEPTIDIC ISOTHIAZOLIDINONE-CONTAINING INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B
2f6f	THE STRUCTURE OF THE S295F MUTANT OF HUMAN PTP1B
2f6t	PROTEIN TYROSINE PHOSPHATASE 1B WITH SULFAMIC ACIDINHIBITORS
2f6v	PROTEIN TYROSINE PHOSPHATASE 1B WITH SULFAMIC ACIDINHIBITORS
2f6w	PROTEIN TYROSINE PHOSPHATASE 1B WITH SULFAMIC ACIDINHIBITORS
2f6y	PROTEIN TYROSINE PHOSPHATASE 1B WITH SULFAMIC ACIDINHIBITORS
2f6z	PROTEIN TYROSINE PHOSPHATASE 1B WITH SULFAMIC ACIDINHIBITORS
2f70	PROTEIN TYROSINE PHOSPHATASE 1B WITH SULFAMIC ACIDINHIBITORS
2f71	PROTEIN TYROSINE PHOSPHATASE 1B WITH SULFAMIC ACIDINHIBITORS
2fjm	THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEXWITH COMPOUND 2
2fjn	THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEXWITH COMPOUND 2
2hnp
2hnq
2veu	CRYSTAL STRUCUTRE OF PROTEIN TYROSINE PHOSPHATASE 1B IN COMPLEX WITH AN ISOTHIAZOLIDINONE-CONTAINING INHIBITOR
2vev	CRYSTAL STRUCUTRE OF PROTEIN TYROSINE PHOSPHATASE 1B IN COMPLEX WITH AN ISOTHIAZOLIDINONE-CONTAINING INHIBITOR
2vex	CRYSTAL STRUCUTRE OF PROTEIN TYROSINE PHOSPHATASE 1B IN COMPLEX WITH AN ISOTHIAZOLIDINONE-CONTAINING INHIBITOR

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (1, 1)

Sites (1, 1)

SS Bonds (0, 0)

Cis Peptide Bonds (0, 0)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (0, 0)

PROSITE Motifs (3, 3)

Exons (8, 8)

Sequences/Alignments